Please login to the form below

Not currently logged in
Email:
Password:

statins

This page shows the latest statins news and features for those working in and with pharma, biotech and healthcare.

Novartis withdraws EU filing for canakinumab

Novartis withdraws EU filing for canakinumab

It noted that the drug had only demonstrated "modest" benefits in the data, particularly in patients who also took statins.

Latest news

More from news
Approximately 11 fully matching, plus 199 partially matching documents found.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    In terms of BACE, Prof Roberts said: “Although the drug companies would love to have a drug that you could take like statins against hypercholesterolaemia, to give long-term protection against

  • Does safety sell medicines? Does safety sell medicines?

    Statins - the most widely prescribed medicines on the planet - might not have been the success story they are without high quality pharmacovigilance detecting the risk of rhabdomyolysis and linking it to

  • Delivering accessible healthcare Delivering accessible healthcare

    Examples of how OTC can help tackle these pressures include the greater availability of statins in some countries and treatments for sexually transmitted diseases that do not require a prescription.

  • Shionogi: an expanding commercial focus Shionogi: an expanding commercial focus

    Perhaps best known for being the company that discovered the blockbuster statin Crestor (rosuvostatin), Shionogi has largely restricted its global focus to R&D.

  • Country report: The healthcare market in Germany Country report: The healthcare market in Germany

    In 1996 new on-patent medicines became exempt unless they were part of classes such as statins to control the impact on spending on 'me-too' drugs.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics